Indications for Invasive ICP Monitoring
ICP monitoring should be placed in patients at risk of elevated intracranial pressure based on clinical and/or imaging features, particularly comatose patients with acute brain injury (ABI), as part of protocol-driven care to guide medical and surgical interventions and detect life-threatening herniation. 1
Primary Indications
Traumatic Brain Injury (TBI)
The most extensively studied indication for ICP monitoring is severe TBI. Place an ICP monitor in patients with:
- Comatose state (GCS ≤8) with abnormal CT findings showing mass lesions, contusions, compressed basal cisterns, midline shift >5mm, or traumatic subarachnoid hemorrhage 1, 2
- Post-operative monitoring after intracranial hematoma evacuation (subdural, epidural, or intraparenchymal) if ANY of the following criteria are present 2:
- Preoperative GCS motor response ≤5
- Preoperative anisocoria or bilateral mydriasis
- Preoperative hemodynamic instability
- Preoperative severity signs on imaging (compressed basal cisterns, midline shift >5mm, presence of other intracranial lesions)
- Intraoperative cerebral edema
- Postoperative appearance of new intracranial lesions
Other Acute Brain Injuries
ICP monitoring plays a similar role in:
When NOT to Monitor
Do NOT place an ICP monitor if the initial CT scan is completely normal with no evidence of clinical severity and no transcranial Doppler abnormalities. 2 The incidence of raised ICP with a strictly normal CT is exceptionally low (0-8%), and the risk-benefit ratio does not support invasive monitoring in this scenario. The exception would be if neurological surveillance is not feasible or the patient has hemodynamic instability requiring case-by-case consideration.
Clinical Context and Nuances
The 2014 International Multidisciplinary Consensus Conference provides strong recommendations (moderate to high quality evidence) that ICP monitoring should be tailored to the specific diagnosis 1. The indications vary across different pathologies—what applies to TBI may differ from SAH or encephalitis management.
Important caveat regarding the BEST-TRIP trial: While this randomized trial showed no outcome difference between ICP monitor-guided care versus clinical examination and imaging-guided care, the study lacks external validity and cannot be generalized 1. Critically, clinical evaluation and diagnosis of elevated ICP was fundamental to ALL patients in BEST-TRIP, reinforcing that evaluation and monitoring—whether by invasive monitor or by clinical and imaging assessment—remains standard of care.
Monitoring as Part of Multimodal Assessment
ICP monitoring is mandatory when other intracranial monitors are used to provide a framework for optimal interpretation 1. The monitor should not be used in isolation but rather integrated with:
- Clinical examination
- Serial imaging
- Cerebral perfusion pressure (CPP) calculation
- Waveform analysis and trending over time 1
The goal is to guide interventions, detect imminent herniation, and maintain adequate cerebral perfusion, recognizing that elevated ICP—particularly when refractory to treatment—is a well-established predictor of mortality 1.
Device Selection
When ICP monitoring is indicated, both parenchymal monitors and external ventricular drains (EVD) are reliable and accurate 1. However, in the presence of hydrocephalus, an EVD is preferred when safe and practical, as it allows both monitoring and therapeutic CSF drainage 1.
The safety profile of ICP monitoring is excellent, with complication rates including catheter placement failure (10%), infection (10% for EVD, 2.5% for parenchymal devices), and intracerebral hemorrhage (2-4% for EVD, 0-1% for parenchymal devices) 2.